# United States Brent Oil Fund, LP: financial statements, quarterly

BNO · NYSE · CIK 1472494 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bno.md) · [Financials](/companies/bno/financials.md) · [Filings](/companies/bno/filings.md) · [Insiders](/companies/bno/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bno/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [38.9](/filings/0001410578-25-000240.md) | [(22.5)](/filings/0001410578-25-000240.md) | [20.6](/filings/0001104659-26-021521.md) | [1.0](/filings/0001104659-26-021521.md) | [(22.0)](/filings/0001104659-26-021521.md) | [12.7](/filings/0001104659-26-021521.md) | [5.2](/filings/0001104659-26-021521.md) | [(6.0)](/filings/0001104659-26-021521.md) | [3.0](/filings/0001104659-26-021521.md) | [(5.2)](/filings/0001104659-26-021521.md) | not reported | not reported |
| Net income | $m | [38.5](/filings/0001410578-25-000240.md) | [(22.9)](/filings/0001410578-25-000240.md) | [20.2](/filings/0001104659-26-021521.md) | [0.6](/filings/0001104659-26-021521.md) | [(22.5)](/filings/0001104659-26-021521.md) | [12.2](/filings/0001104659-26-021521.md) | [4.9](/filings/0001104659-26-057778.md) | [(6.2)](/filings/0001104659-26-092631.md) | [2.7](/filings/0001104659-26-021521.md) | [(5.5)](/filings/0001104659-26-021521.md) | [166](/filings/0001104659-26-057778.md) | [(209)](/filings/0001104659-26-092631.md) |

- Revenue: us-gaap:Revenues
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [118](/filings/0001410578-24-001820.md) | [78.7](/filings/0001104659-26-021521.md) | [93.4](/filings/0001410578-25-001158.md) | [91.6](/filings/0001410578-25-001639.md) | [182](/filings/0001104659-25-108402.md) | [80.1](/filings/0001104659-26-021521.md) | [61.9](/filings/0001104659-26-057778.md) | [82.0](/filings/0001104659-26-092631.md) | [83.7](/filings/0001104659-25-108402.md) | [86.5](/filings/0001104659-26-092631.md) | [871](/filings/0001104659-26-057778.md) | [394](/filings/0001104659-26-092631.md) |
| Total assets | $m | [170](/filings/0001410578-23-002203.md) | [130](/filings/0001410578-25-000240.md) | [134](/filings/0001410578-24-000706.md) | [129](/filings/0001410578-24-001232.md) | [217](/filings/0001410578-24-001820.md) | [115](/filings/0001104659-26-021521.md) | [98.3](/filings/0001410578-25-001158.md) | [104](/filings/0001410578-25-001639.md) | [102](/filings/0001104659-25-108402.md) | [101](/filings/0001104659-26-092631.md) | [952](/filings/0001104659-26-057778.md) | [544](/filings/0001104659-26-092631.md) |
| Total liabilities | $m | [0.2](/filings/0001410578-23-002203.md) | [0.3](/filings/0001410578-25-000240.md) | [0.2](/filings/0001410578-24-000706.md) | [0.2](/filings/0001410578-24-001232.md) | [0.3](/filings/0001410578-24-001820.md) | [0.3](/filings/0001104659-26-021521.md) | [0.3](/filings/0001410578-25-001158.md) | [0.2](/filings/0001410578-25-001639.md) | [0.3](/filings/0001104659-25-108402.md) | [0.3](/filings/0001104659-26-092631.md) | [0.5](/filings/0001104659-26-057778.md) | [0.7](/filings/0001104659-26-092631.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [38.6 d](/filings/0001410578-24-001820.md) | [(22.9) d](/filings/0001104659-26-021521.md) | [16.8](/filings/0001410578-25-001158.md) | [1.0 d](/filings/0001410578-25-001639.md) | [(16.9) d](/filings/0001104659-25-108402.md) | [6.1 d](/filings/0001104659-26-021521.md) | [2.1](/filings/0001104659-26-057778.md) | [9.7 d](/filings/0001104659-26-092631.md) | [(6.1) d](/filings/0001104659-25-108402.md) | [(9.4) d](/filings/0001104659-26-021521.md) | [165](/filings/0001104659-26-057778.md) | [(163) d](/filings/0001104659-26-092631.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 12,400,000 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092631.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.